Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
345 Leser
Artikel bewerten:
(0)

VWR Acquires EPL Archives, Inc.

Acquisition will Expand VWRCATALYST Services Portfolio

RADNOR, Pennsylvania, March 22, 2017 /PRNewswire/ --VWR (NASDAQ: VWR), the leading global independent provider of product and service solutions to laboratory and production customers, announced today that it has acquired EPL Archives, Inc., an international biorepository services organization that supports customers across the entire regulated product research, development and commercialization lifecycle by providing archive sample, document storage and ancillary services. EPL Archives is widely recognized and respected by its customers for consistently delivering high-quality, responsive and compliant professional material management services.

"EPL Archives is a well-known and trusted partner to the majority of the world's largest pharmaceutical customers, including many existing VWR customers," said Manuel Brocke-Benz, President and CEO of VWR. "Their portfolio of services will greatly complement VWR's current service offering, as a part of VWRCATALYST, allowing us to better serve our customers in achieving their goals by ensuring compliant storage of research, manufacturing and clinical trial materials."

Founded in 1978, EPL Archives has several locations in Virginia, U.S. and Carros, France. EPL Archives operates biostorage facilities totaling over 190,000 square feet of storage space including temperature controlled, humidity controlled and ambient storage that are compliant with applicable GLP, GCP and GMP regulations. Services include non-clinical archiving, clinical biorepository and bio banking, regulated data management, manufacturing material storage, and specialized logistics and support services.

Financial details of this acquisition remain confidential.

About VWR

VWR(NASDAQ:VWR), headquartered inRadnor,Pennsylvania, is the leading global independent provider of product and service solutions to laboratory and production customers. With sales in excess of$4.5billionin 2016, VWR enables science for customers in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries. With more than 160 years of experience, VWR has cultivated a value proposition delivering product choice, operational excellence and differentiated services to improve our customers' productivity from research to production. VWR's differentiated services provide innovative, flexible and customized solutions from scientific research services to custom-manufactured chemical blends. Our dedicated team of more than 10,200 associates is focused on supporting scientists, medical professionals and production engineers to achieve their goals.

For more information on VWR, please visitwww.vwr.com.

Media Contact:
Valerie Collado
Director, Corporate Communications
VWR International, LLC
484.885.9338
Valerie_collado@vwr.com

Investor Contact:
John Sweeney, CFA
VP, Investor Relations
VWR Corporation
Phone: +610.386.1483
ir@vwr.com

VWR International, LLC Logo

Logo - https://mma.prnewswire.com/media/95343/vwr_international__llc_logo.jpg

Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.